Pfizer picks up Brazil's Teuto in $240M deal

Pfizer will pay $240 million for a 40 percent stake in Brazil's Laboratorio Teuto Brasileiro, a generics specialist, as it expands further in emerging markets. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.